| PERSONALIS INC. DL-,001 |
| USA |
| Gesundheit |
| US71535D1063 / A2PLTK |
| 04X (Frankfurt) / PSNL (NASDAQ) |
| FRA:04X, ETR:04X, 04X:GR, NASDAQ:PSNL |
| - |
| https://www.personalis.co.. |
|
Personalis Inc. is a biotechnology company specializing in advanced genomics services for precision medicine and oncology. Its primary function is to analyze complex genetic information for clinical and academic research, aiding in the development of..
>Volltext.. |
| 594.63 Mio. EUR |
| 425.15 Mio. EUR |
| 60.34 Mio. EUR |
| -67.58 Mio. EUR |
| -70.41 Mio. EUR |
| -0.79 EUR |
| 35.35 Mio. EUR |
| 107.64 Mio. EUR |
| -64.93 Mio. EUR |
| 6.05 |
| -27.45% |
| 11.87% |
| - |
| - |
| - |
| - |
| PERSONALIS |
| 05.04.26 |